Charles E. Sheedy, 10% Owner at Nuo Therapeutics, Inc. (AURX), bought 175,000 shares at $0.40 ($70K) on 2020-10-05, disclosed to the SEC on 2022-04-26.
Open-market purchase of $70k AURX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| AURX | BUY | 2024-05-21 | $75K | — | Filing → |
| AURX | BUY | 2023-12-20 | $75K | — | Filing → |
| AURX | BUY | 2023-08-04 | $125K | — | Filing → |